WINSTON-SALEM, NC, December 13, 2023 – The Wake Forest Institute for Regenerative Medicine (WFIRM) has received a $6 million grant from the National Institute for Diabetes, Digestive and Kidney Diseases, part of the National Institutes of Health. Alongside five other North Carolina institutions, the collaborative effort aims to address critical issues and advance research in ..read more

University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology (ASH) Annual Meeting, held Dec. 9-12 in San Diego, California.  Credit: Photo/UC Health University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology (ASH) Annual Meeting, held Dec. 9-12 in San Diego, California.  Trial finds ..read more

Investigators from the Mass General Cancer Center, a part of the Mass General Brigham healthcare system, will present research discoveries and outcomes from clinical trials at the 2023 American Society of Hematology (ASH) Annual Meeting, held December 9-12, 2023 in San Diego. ASH brings together leading experts in classical and malignant blood diseases to share ..read more

Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and PrECOG, LLC, will present six oral and three poster presentations at the 65th American Society of Hematology (ASH) Meeting & Exposition, occurring in San Diego, California and virtually December 9-12, 2023. The presentations focus on treatments for acute leukemias and lymphomas.   Among the data are the ..read more

–  Of the 14 participants enrolled and treated with lenzilumab plus azacitidine, ten are evaluable with three to eighteen months of follow-up and all ten have had a rapid clinical response Credit: Humanigen –  Of the 14 participants enrolled and treated with lenzilumab plus azacitidine, ten are evaluable with three to eighteen months of follow-up ..read more

HOBOKEN, NJ, USA and THE HAGUE, THE NETHERLANDS – June 9, 2023 – Wiley, one of the world’s largest publishers and a global leader in research and education, today announced that it will publish the open access journal HemaSphere on behalf of the European Hematology Association (EHA), the largest community of European hematologists, beginning in ..read more

Researchers find pre-transplant cardiovascular diseases indirectly affect mortality and survival through increased post-transplant disease occurrence Credit: Chinese Medical Journal Hematopoietic cell transplantation (HCT) is a recognized treatment option for certain blood and bone marrow cancers as well as some autoimmune and hereditary disorders. Performed to replace or modulate the body’s malfunctioning hematopoietic system (which produces ..read more

During the height of the pandemic, some hospitals were overwhelmed with patients seeking treatment for COVID-19. This situation could happen again during future outbreaks, especially with SARS-CoV-2 variants of concern on the rise. Now, researchers reporting in ACS’ Analytical Chemistry have developed a blood test to predict which people infected with COVID-19 are most likely ..read more

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. New research published in the Journal of Leukocyte Biology reveals that certain protein markers may indicate which patients have stable forms of CLL and which have more aggressive types. Identifying these proteins may not only help determine patients’ prognoses but also point ..read more

A scientific review has found evidence that a disruption in blood clotting and the first line immune system could be contributing factors in the development of psychosis. The article, a joint collaborative effort by researchers at RCSI University of Medicine and Health Sciences, Cardiff University and the UCD Conway Institute, is published in Molecular Psychiatry ..read more